Global and Japan Direct-acting Antiviral Drugs Market Size, Status and Forecast 2021-2027

SKU ID : QYR-19220960 | Publishing Date : 24-Sep-2021 | No. of pages : 106

Detailed TOC of Global and Japan Direct-acting Antiviral Drugs Market Size, Status and Forecast 2021-2027

1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Direct-acting Antiviral Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 NS3/4A Protease Inhibitors
        1.2.3 Nucleoside and Nucleotide NS5B Polymerase Inhibitors
        1.2.4 NS5A Inhibitors
        1.2.5 Non-Nucleoside NS5B Polymerase Inhibitors
    1.3 Market by Application
        1.3.1 Global Direct-acting Antiviral Drugs Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 Ambulatory Surgical Centers
        1.3.5 Pharmacies
        1.3.6 Others
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Direct-acting Antiviral Drugs Market Perspective (2016-2027)
    2.2 Direct-acting Antiviral Drugs Growth Trends by Regions
        2.2.1 Direct-acting Antiviral Drugs Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Direct-acting Antiviral Drugs Historic Market Share by Regions (2016-2021)
        2.2.3 Direct-acting Antiviral Drugs Forecasted Market Size by Regions (2022-2027)
    2.3 Direct-acting Antiviral Drugs Industry Dynamic
        2.3.1 Direct-acting Antiviral Drugs Market Trends
        2.3.2 Direct-acting Antiviral Drugs Market Drivers
        2.3.3 Direct-acting Antiviral Drugs Market Challenges
        2.3.4 Direct-acting Antiviral Drugs Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Direct-acting Antiviral Drugs Players by Revenue
        3.1.1 Global Top Direct-acting Antiviral Drugs Players by Revenue (2016-2021)
        3.1.2 Global Direct-acting Antiviral Drugs Revenue Market Share by Players (2016-2021)
    3.2 Global Direct-acting Antiviral Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Direct-acting Antiviral Drugs Revenue
    3.4 Global Direct-acting Antiviral Drugs Market Concentration Ratio
        3.4.1 Global Direct-acting Antiviral Drugs Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Direct-acting Antiviral Drugs Revenue in 2020
    3.5 Direct-acting Antiviral Drugs Key Players Head office and Area Served
    3.6 Key Players Direct-acting Antiviral Drugs Product Solution and Service
    3.7 Date of Enter into Direct-acting Antiviral Drugs Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Direct-acting Antiviral Drugs Breakdown Data by Type
    4.1 Global Direct-acting Antiviral Drugs Historic Market Size by Type (2016-2021)
    4.2 Global Direct-acting Antiviral Drugs Forecasted Market Size by Type (2022-2027)

5 Direct-acting Antiviral Drugs Breakdown Data by Application
    5.1 Global Direct-acting Antiviral Drugs Historic Market Size by Application (2016-2021)
    5.2 Global Direct-acting Antiviral Drugs Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Direct-acting Antiviral Drugs Market Size (2016-2027)
    6.2 North America Direct-acting Antiviral Drugs Market Size by Type
        6.2.1 North America Direct-acting Antiviral Drugs Market Size by Type (2016-2021)
        6.2.2 North America Direct-acting Antiviral Drugs Market Size by Type (2022-2027)
        6.2.3 North America Direct-acting Antiviral Drugs Market Size by Type (2016-2027)
    6.3 North America Direct-acting Antiviral Drugs Market Size by Application
        6.3.1 North America Direct-acting Antiviral Drugs Market Size by Application (2016-2021)
        6.3.2 North America Direct-acting Antiviral Drugs Market Size by Application (2022-2027)
        6.3.3 North America Direct-acting Antiviral Drugs Market Size by Application (2016-2027)
    6.4 North America Direct-acting Antiviral Drugs Market Size by Country
        6.4.1 North America Direct-acting Antiviral Drugs Market Size by Country (2016-2021)
        6.4.2 North America Direct-acting Antiviral Drugs Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Direct-acting Antiviral Drugs Market Size (2016-2027)
    7.2 Europe Direct-acting Antiviral Drugs Market Size by Type
        7.2.1 Europe Direct-acting Antiviral Drugs Market Size by Type (2016-2021)
        7.2.2 Europe Direct-acting Antiviral Drugs Market Size by Type (2022-2027)
        7.2.3 Europe Direct-acting Antiviral Drugs Market Size by Type (2016-2027)
    7.3 Europe Direct-acting Antiviral Drugs Market Size by Application
        7.3.1 Europe Direct-acting Antiviral Drugs Market Size by Application (2016-2021)
        7.3.2 Europe Direct-acting Antiviral Drugs Market Size by Application (2022-2027)
        7.3.3 Europe Direct-acting Antiviral Drugs Market Size by Application (2016-2027)
    7.4 Europe Direct-acting Antiviral Drugs Market Size by Country
        7.4.1 Europe Direct-acting Antiviral Drugs Market Size by Country (2016-2021)
        7.4.2 Europe Direct-acting Antiviral Drugs Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Direct-acting Antiviral Drugs Market Size (2016-2027)
    8.2 Asia-Pacific Direct-acting Antiviral Drugs Market Size by Type
        8.2.1 Asia-Pacific Direct-acting Antiviral Drugs Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Direct-acting Antiviral Drugs Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Direct-acting Antiviral Drugs Market Size by Type (2016-2027)
    8.3 Asia-Pacific Direct-acting Antiviral Drugs Market Size by Application
        8.3.1 Asia-Pacific Direct-acting Antiviral Drugs Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Direct-acting Antiviral Drugs Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Direct-acting Antiviral Drugs Market Size by Application (2016-2027)
    8.4 Asia-Pacific Direct-acting Antiviral Drugs Market Size by Region
        8.4.1 Asia-Pacific Direct-acting Antiviral Drugs Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Direct-acting Antiviral Drugs Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Direct-acting Antiviral Drugs Market Size (2016-2027)
    9.2 Latin America Direct-acting Antiviral Drugs Market Size by Type
        9.2.1 Latin America Direct-acting Antiviral Drugs Market Size by Type (2016-2021)
        9.2.2 Latin America Direct-acting Antiviral Drugs Market Size by Type (2022-2027)
        9.2.3 Latin America Direct-acting Antiviral Drugs Market Size by Type (2016-2027)
    9.3 Latin America Direct-acting Antiviral Drugs Market Size by Application
        9.3.1 Latin America Direct-acting Antiviral Drugs Market Size by Application (2016-2021)
        9.3.2 Latin America Direct-acting Antiviral Drugs Market Size by Application (2022-2027)
        9.3.3 Latin America Direct-acting Antiviral Drugs Market Size by Application (2016-2027)
    9.4 Latin America Direct-acting Antiviral Drugs Market Size by Country
        9.4.1 Latin America Direct-acting Antiviral Drugs Market Size by Country (2016-2021)
        9.4.2 Latin America Direct-acting Antiviral Drugs Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Direct-acting Antiviral Drugs Market Size (2016-2027)
    10.2 Middle East & Africa Direct-acting Antiviral Drugs Market Size by Type
        10.2.1 Middle East & Africa Direct-acting Antiviral Drugs Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Direct-acting Antiviral Drugs Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Direct-acting Antiviral Drugs Market Size by Type (2016-2027)
    10.3 Middle East & Africa Direct-acting Antiviral Drugs Market Size by Application
        10.3.1 Middle East & Africa Direct-acting Antiviral Drugs Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Direct-acting Antiviral Drugs Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Direct-acting Antiviral Drugs Market Size by Application (2016-2027)
    10.4 Middle East & Africa Direct-acting Antiviral Drugs Market Size by Country
        10.4.1 Middle East & Africa Direct-acting Antiviral Drugs Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Direct-acting Antiviral Drugs Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 AbbVie Inc.
        11.1.1 AbbVie Inc. Company Details
        11.1.2 AbbVie Inc. Business Overview
        11.1.3 AbbVie Inc. Direct-acting Antiviral Drugs Introduction
        11.1.4 AbbVie Inc. Revenue in Direct-acting Antiviral Drugs Business (2016-2021)
        11.1.5 AbbVie Inc. Recent Development
    11.2 GSK
        11.2.1 GSK Company Details
        11.2.2 GSK Business Overview
        11.2.3 GSK Direct-acting Antiviral Drugs Introduction
        11.2.4 GSK Revenue in Direct-acting Antiviral Drugs Business (2016-2021)
        11.2.5 GSK Recent Development
    11.3 Boehringer Ingelheim
        11.3.1 Boehringer Ingelheim Company Details
        11.3.2 Boehringer Ingelheim Business Overview
        11.3.3 Boehringer Ingelheim Direct-acting Antiviral Drugs Introduction
        11.3.4 Boehringer Ingelheim Revenue in Direct-acting Antiviral Drugs Business (2016-2021)
        11.3.5 Boehringer Ingelheim Recent Development
    11.4 Merck
        11.4.1 Merck Company Details
        11.4.2 Merck Business Overview
        11.4.3 Merck Direct-acting Antiviral Drugs Introduction
        11.4.4 Merck Revenue in Direct-acting Antiviral Drugs Business (2016-2021)
        11.4.5 Merck Recent Development
    11.5 Novartis
        11.5.1 Novartis Company Details
        11.5.2 Novartis Business Overview
        11.5.3 Novartis Direct-acting Antiviral Drugs Introduction
        11.5.4 Novartis Revenue in Direct-acting Antiviral Drugs Business (2016-2021)
        11.5.5 Novartis Recent Development
    11.6 Beximco Pharmaceuticals
        11.6.1 Beximco Pharmaceuticals Company Details
        11.6.2 Beximco Pharmaceuticals Business Overview
        11.6.3 Beximco Pharmaceuticals Direct-acting Antiviral Drugs Introduction
        11.6.4 Beximco Pharmaceuticals Revenue in Direct-acting Antiviral Drugs Business (2016-2021)
        11.6.5 Beximco Pharmaceuticals Recent Development
    11.7 Roche
        11.7.1 Roche Company Details
        11.7.2 Roche Business Overview
        11.7.3 Roche Direct-acting Antiviral Drugs Introduction
        11.7.4 Roche Revenue in Direct-acting Antiviral Drugs Business (2016-2021)
        11.7.5 Roche Recent Development
    11.8 Bristol-Myers Squibb Company
        11.8.1 Bristol-Myers Squibb Company Company Details
        11.8.2 Bristol-Myers Squibb Company Business Overview
        11.8.3 Bristol-Myers Squibb Company Direct-acting Antiviral Drugs Introduction
        11.8.4 Bristol-Myers Squibb Company Revenue in Direct-acting Antiviral Drugs Business (2016-2021)
        11.8.5 Bristol-Myers Squibb Company Recent Development
    11.9 Gilead Sciences
        11.9.1 Gilead Sciences Company Details
        11.9.2 Gilead Sciences Business Overview
        11.9.3 Gilead Sciences Direct-acting Antiviral Drugs Introduction
        11.9.4 Gilead Sciences Revenue in Direct-acting Antiviral Drugs Business (2016-2021)
        11.9.5 Gilead Sciences Recent Development
    11.10 Janssen (Johnson & Johnson)
        11.10.1 Janssen (Johnson & Johnson) Company Details
        11.10.2 Janssen (Johnson & Johnson) Business Overview
        11.10.3 Janssen (Johnson & Johnson) Direct-acting Antiviral Drugs Introduction
        11.10.4 Janssen (Johnson & Johnson) Revenue in Direct-acting Antiviral Drugs Business (2016-2021)
        11.10.5 Janssen (Johnson & Johnson) Recent Development
    11.11 Vertex Pharmaceuticals
        11.11.1 Vertex Pharmaceuticals Company Details
        11.11.2 Vertex Pharmaceuticals Business Overview
        11.11.3 Vertex Pharmaceuticals Direct-acting Antiviral Drugs Introduction
        11.11.4 Vertex Pharmaceuticals Revenue in Direct-acting Antiviral Drugs Business (2016-2021)
        11.11.5 Vertex Pharmaceuticals Recent Development
    11.12 Natco Pharma
        11.12.1 Natco Pharma Company Details
        11.12.2 Natco Pharma Business Overview
        11.12.3 Natco Pharma Direct-acting Antiviral Drugs Introduction
        11.12.4 Natco Pharma Revenue in Direct-acting Antiviral Drugs Business (2016-2021)
        11.12.5 Natco Pharma Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Figures, Tables and Charts Available in Global and Japan Direct-acting Antiviral Drugs Market Size, Status and Forecast 2021-2027

List of Tables
    Table 1. Global Direct-acting Antiviral Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of NS3/4A Protease Inhibitors
    Table 3. Key Players of Nucleoside and Nucleotide NS5B Polymerase Inhibitors
    Table 4. Key Players of NS5A Inhibitors
    Table 5. Key Players of Non-Nucleoside NS5B Polymerase Inhibitors
    Table 6. Global Direct-acting Antiviral Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 7. Global Direct-acting Antiviral Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 8. Global Direct-acting Antiviral Drugs Market Size by Regions (2016-2021) & (US$ Million)
    Table 9. Global Direct-acting Antiviral Drugs Market Share by Regions (2016-2021)
    Table 10. Global Direct-acting Antiviral Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 11. Global Direct-acting Antiviral Drugs Market Share by Regions (2022-2027)
    Table 12. Direct-acting Antiviral Drugs Market Trends
    Table 13. Direct-acting Antiviral Drugs Market Drivers
    Table 14. Direct-acting Antiviral Drugs Market Challenges
    Table 15. Direct-acting Antiviral Drugs Market Restraints
    Table 16. Global Direct-acting Antiviral Drugs Revenue by Players (2016-2021) & (US$ Million)
    Table 17. Global Direct-acting Antiviral Drugs Market Share by Players (2016-2021)
    Table 18. Global Top Direct-acting Antiviral Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Direct-acting Antiviral Drugs as of 2020)
    Table 19. Ranking of Global Top Direct-acting Antiviral Drugs Companies by Revenue (US$ Million) in 2020
    Table 20. Global 5 Largest Players Market Share by Direct-acting Antiviral Drugs Revenue (CR5 and HHI) & (2016-2021)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Direct-acting Antiviral Drugs Product Solution and Service
    Table 23. Date of Enter into Direct-acting Antiviral Drugs Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Direct-acting Antiviral Drugs Market Size by Type (2016-2021) (US$ Million)
    Table 26. Global Direct-acting Antiviral Drugs Revenue Market Share by Type (2016-2021)
    Table 27. Global Direct-acting Antiviral Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 28. Global Direct-acting Antiviral Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 29. Global Direct-acting Antiviral Drugs Market Size Share by Application (2016-2021) & (US$ Million)
    Table 30. Global Direct-acting Antiviral Drugs Revenue Market Share by Application (2016-2021)
    Table 31. Global Direct-acting Antiviral Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 32. Global Direct-acting Antiviral Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 33. North America Direct-acting Antiviral Drugs Market Size by Type (2016-2021) (US$ Million)
    Table 34. North America Direct-acting Antiviral Drugs Market Size by Type (2022-2027) & (US$ Million)
    Table 35. North America Direct-acting Antiviral Drugs Market Size by Application (2016-2021) (US$ Million)
    Table 36. North America Direct-acting Antiviral Drugs Market Size by Application (2022-2027) & (US$ Million)
    Table 37. North America Direct-acting Antiviral Drugs Market Size by Country (2016-2021) & (US$ Million)
    Table 38. North America Direct-acting Antiviral Drugs Market Size by Country (2022-2027) & (US$ Million)
    Table 39. Europe Direct-acting Antiviral Drugs Market Size by Type (2016-2021) (US$ Million)
    Table 40. Europe Direct-acting Antiviral Drugs Market Size by Type (2022-2027) & (US$ Million)
    Table 41. Europe Direct-acting Antiviral Drugs Market Size by Application (2016-2021) (US$ Million)
    Table 42. Europe Direct-acting Antiviral Drugs Market Size by Application (2022-2027) & (US$ Million)
    Table 43. Europe Direct-acting Antiviral Drugs Market Size by Country (2016-2021) & (US$ Million)
    Table 44. Europe Direct-acting Antiviral Drugs Market Size by Country (2022-2027) & (US$ Million)
    Table 45. Asia-Pacific Direct-acting Antiviral Drugs Market Size by Type (2016-2021) (US$ Million)
    Table 46. Asia-Pacific Direct-acting Antiviral Drugs Market Size by Type (2022-2027) & (US$ Million)
    Table 47. Asia-Pacific Direct-acting Antiviral Drugs Market Size by Application (2016-2021) (US$ Million)
    Table 48. Asia-Pacific Direct-acting Antiviral Drugs Market Size by Application (2022-2027) & (US$ Million)
    Table 49. Asia-Pacific Direct-acting Antiviral Drugs Market Size by Region (2016-2021) & (US$ Million)
    Table 50. Asia-Pacific Direct-acting Antiviral Drugs Market Size by Region (2022-2027) & (US$ Million)
    Table 51. Latin America Direct-acting Antiviral Drugs Market Size by Type (2016-2021) (US$ Million)
    Table 52. Latin America Direct-acting Antiviral Drugs Market Size by Type (2022-2027) & (US$ Million)
    Table 53. Latin America Direct-acting Antiviral Drugs Market Size by Application (2016-2021) (US$ Million)
    Table 54. Latin America Direct-acting Antiviral Drugs Market Size by Application (2022-2027) & (US$ Million)
    Table 55. Latin America Direct-acting Antiviral Drugs Market Size by Country (2016-2021) & (US$ Million)
    Table 56. Latin America Direct-acting Antiviral Drugs Market Size by Country (2022-2027) & (US$ Million)
    Table 57. Middle East & Africa Direct-acting Antiviral Drugs Market Size by Type (2016-2021) (US$ Million)
    Table 58. Middle East & Africa Direct-acting Antiviral Drugs Market Size by Type (2022-2027) & (US$ Million)
    Table 59. Middle East & Africa Direct-acting Antiviral Drugs Market Size by Application (2016-2021) (US$ Million)
    Table 60. Middle East & Africa Direct-acting Antiviral Drugs Market Size by Application (2022-2027) & (US$ Million)
    Table 61. Middle East & Africa Direct-acting Antiviral Drugs Market Size by Country (2016-2021) & (US$ Million)
    Table 62. Middle East & Africa Direct-acting Antiviral Drugs Market Size by Country (2022-2027) & (US$ Million)
    Table 63. AbbVie Inc. Company Details
    Table 64. AbbVie Inc. Business Overview
    Table 65. AbbVie Inc. Direct-acting Antiviral Drugs Product
    Table 66. AbbVie Inc. Revenue in Direct-acting Antiviral Drugs Business (2016-2021) & (US$ Million)
    Table 67. AbbVie Inc. Recent Development
    Table 68. GSK Company Details
    Table 69. GSK Business Overview
    Table 70. GSK Direct-acting Antiviral Drugs Product
    Table 71. GSK Revenue in Direct-acting Antiviral Drugs Business (2016-2021) & (US$ Million)
    Table 72. GSK Recent Development
    Table 73. Boehringer Ingelheim Company Details
    Table 74. Boehringer Ingelheim Business Overview
    Table 75. Boehringer Ingelheim Direct-acting Antiviral Drugs Product
    Table 76. Boehringer Ingelheim Revenue in Direct-acting Antiviral Drugs Business (2016-2021) & (US$ Million)
    Table 77. Boehringer Ingelheim Recent Development
    Table 78. Merck Company Details
    Table 79. Merck Business Overview
    Table 80. Merck Direct-acting Antiviral Drugs Product
    Table 81. Merck Revenue in Direct-acting Antiviral Drugs Business (2016-2021) & (US$ Million)
    Table 82. Merck Recent Development
    Table 83. Novartis Company Details
    Table 84. Novartis Business Overview
    Table 85. Novartis Direct-acting Antiviral Drugs Product
    Table 86. Novartis Revenue in Direct-acting Antiviral Drugs Business (2016-2021) & (US$ Million)
    Table 87. Novartis Recent Development
    Table 88. Beximco Pharmaceuticals Company Details
    Table 89. Beximco Pharmaceuticals Business Overview
    Table 90. Beximco Pharmaceuticals Direct-acting Antiviral Drugs Product
    Table 91. Beximco Pharmaceuticals Revenue in Direct-acting Antiviral Drugs Business (2016-2021) & (US$ Million)
    Table 92. Beximco Pharmaceuticals Recent Development
    Table 93. Roche Company Details
    Table 94. Roche Business Overview
    Table 95. Roche Direct-acting Antiviral Drugs Product
    Table 96. Roche Revenue in Direct-acting Antiviral Drugs Business (2016-2021) & (US$ Million)
    Table 97. Roche Recent Development
    Table 98. Bristol-Myers Squibb Company Company Details
    Table 99. Bristol-Myers Squibb Company Business Overview
    Table 100. Bristol-Myers Squibb Company Revenue in Direct-acting Antiviral Drugs Business (2016-2021) & (US$ Million)
    Table 101. Bristol-Myers Squibb Company Recent Development
    Table 102. Gilead Sciences Company Details
    Table 103. Gilead Sciences Business Overview
    Table 104. Gilead Sciences Direct-acting Antiviral Drugs Product
    Table 105. Gilead Sciences Revenue in Direct-acting Antiviral Drugs Business (2016-2021) & (US$ Million)
    Table 106. Gilead Sciences Recent Development
    Table 107. Janssen (Johnson & Johnson) Company Details
    Table 108. Janssen (Johnson & Johnson) Business Overview
    Table 109. Janssen (Johnson & Johnson) Direct-acting Antiviral Drugs Product
    Table 110. Janssen (Johnson & Johnson) Revenue in Direct-acting Antiviral Drugs Business (2016-2021) & (US$ Million)
    Table 111. Janssen (Johnson & Johnson) Recent Development
    Table 112. Vertex Pharmaceuticals Company Details
    Table 113. Vertex Pharmaceuticals Business Overview
    Table 114. Vertex Pharmaceuticals Direct-acting Antiviral Drugs Product
    Table 115. Vertex Pharmaceuticals Revenue in Direct-acting Antiviral Drugs Business (2016-2021) & (US$ Million)
    Table 116. Vertex Pharmaceuticals Recent Development
    Table 117. Natco Pharma Company Details
    Table 118. Natco Pharma Business Overview
    Table 119. Natco Pharma Direct-acting Antiviral Drugs Product
    Table 120. Natco Pharma Revenue in Direct-acting Antiviral Drugs Business (2016-2021) & (US$ Million)
    Table 121. Natco Pharma Recent Development
    Table 122. Research Programs/Design for This Report
    Table 123. Key Data Information from Secondary Sources
    Table 124. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Direct-acting Antiviral Drugs Market Share by Type: 2020 VS 2027
    Figure 2. NS3/4A Protease Inhibitors Features
    Figure 3. Nucleoside and Nucleotide NS5B Polymerase Inhibitors Features
    Figure 4. NS5A Inhibitors Features
    Figure 5. Non-Nucleoside NS5B Polymerase Inhibitors Features
    Figure 6. Global Direct-acting Antiviral Drugs Market Share by Application: 2020 VS 2027
    Figure 7. Hospitals Case Studies
    Figure 8. Clinics Case Studies
    Figure 9. Ambulatory Surgical Centers Case Studies
    Figure 10. Pharmacies Case Studies
    Figure 11. Others Case Studies
    Figure 12. Direct-acting Antiviral Drugs Report Years Considered
    Figure 13. Global Direct-acting Antiviral Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 14. Global Direct-acting Antiviral Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 15. Global Direct-acting Antiviral Drugs Market Share by Regions: 2020 VS 2027
    Figure 16. Global Direct-acting Antiviral Drugs Market Share by Regions (2022-2027)
    Figure 17. Global Direct-acting Antiviral Drugs Market Share by Players in 2020
    Figure 18. Global Top Direct-acting Antiviral Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Direct-acting Antiviral Drugs as of 2020
    Figure 19. The Top 10 and 5 Players Market Share by Direct-acting Antiviral Drugs Revenue in 2020
    Figure 20. Global Direct-acting Antiviral Drugs Revenue Market Share by Type (2016-2021)
    Figure 21. Global Direct-acting Antiviral Drugs Revenue Market Share by Type (2022-2027)
    Figure 22. North America Direct-acting Antiviral Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 23. North America Direct-acting Antiviral Drugs Market Share by Type (2016-2027)
    Figure 24. North America Direct-acting Antiviral Drugs Market Share by Application (2016-2027)
    Figure 25. North America Direct-acting Antiviral Drugs Market Share by Country (2016-2027)
    Figure 26. United States Direct-acting Antiviral Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 27. Canada Direct-acting Antiviral Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 28. Europe Direct-acting Antiviral Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 29. Europe Direct-acting Antiviral Drugs Market Share by Type (2016-2027)
    Figure 30. Europe Direct-acting Antiviral Drugs Market Share by Application (2016-2027)
    Figure 31. Europe Direct-acting Antiviral Drugs Market Share by Country (2016-2027)
    Figure 32. Germany Direct-acting Antiviral Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. France Direct-acting Antiviral Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. U.K. Direct-acting Antiviral Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Italy Direct-acting Antiviral Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Russia Direct-acting Antiviral Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 37. Nordic Direct-acting Antiviral Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 38. Asia-Pacific Direct-acting Antiviral Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 39. Asia-Pacific Direct-acting Antiviral Drugs Market Share by Type (2016-2027)
    Figure 40. Asia-Pacific Direct-acting Antiviral Drugs Market Share by Application (2016-2027)
    Figure 41. Asia-Pacific Direct-acting Antiviral Drugs Market Share by Region (2016-2027)
    Figure 42. China Direct-acting Antiviral Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. Japan Direct-acting Antiviral Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. South Korea Direct-acting Antiviral Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Southeast Asia Direct-acting Antiviral Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. India Direct-acting Antiviral Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 47. Australia Direct-acting Antiviral Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 48. Latin America Direct-acting Antiviral Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 49. Latin America Direct-acting Antiviral Drugs Market Share by Type (2016-2027)
    Figure 50. Latin America Direct-acting Antiviral Drugs Market Share by Application (2016-2027)
    Figure 51. Latin America Direct-acting Antiviral Drugs Market Share by Country (2016-2027)
    Figure 52. Mexico Direct-acting Antiviral Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 53. Brazil Direct-acting Antiviral Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 54. Middle East & Africa Direct-acting Antiviral Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 55. Middle East & Africa Direct-acting Antiviral Drugs Market Share by Type (2016-2027)
    Figure 56. Middle East & Africa Direct-acting Antiviral Drugs Market Share by Application (2016-2027)
    Figure 57. Middle East & Africa Direct-acting Antiviral Drugs Market Share by Country (2016-2027)
    Figure 58. Turkey Direct-acting Antiviral Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 59. Saudi Arabia Direct-acting Antiviral Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 60. UAE Direct-acting Antiviral Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 61. AbbVie Inc. Revenue Growth Rate in Direct-acting Antiviral Drugs Business (2016-2021)
    Figure 62. GSK Revenue Growth Rate in Direct-acting Antiviral Drugs Business (2016-2021)
    Figure 63. Boehringer Ingelheim Revenue Growth Rate in Direct-acting Antiviral Drugs Business (2016-2021)
    Figure 64. Merck Revenue Growth Rate in Direct-acting Antiviral Drugs Business (2016-2021)
    Figure 65. Novartis Revenue Growth Rate in Direct-acting Antiviral Drugs Business (2016-2021)
    Figure 66. Beximco Pharmaceuticals Revenue Growth Rate in Direct-acting Antiviral Drugs Business (2016-2021)
    Figure 67. Roche Revenue Growth Rate in Direct-acting Antiviral Drugs Business (2016-2021)
    Figure 68. Bristol-Myers Squibb Company Revenue Growth Rate in Direct-acting Antiviral Drugs Business (2016-2021)
    Figure 69. Gilead Sciences Revenue Growth Rate in Direct-acting Antiviral Drugs Business (2016-2021)
    Figure 70. Janssen (Johnson & Johnson) Revenue Growth Rate in Direct-acting Antiviral Drugs Business (2016-2021)
    Figure 71. Vertex Pharmaceuticals Revenue Growth Rate in Direct-acting Antiviral Drugs Business (2016-2021)
    Figure 72. Natco Pharma Revenue Growth Rate in Direct-acting Antiviral Drugs Business (2016-2021)
    Figure 73. Bottom-up and Top-down Approaches for This Report
    Figure 74. Data Triangulation
    Figure 75. Key Executives Interviewed

Keyplayers in Global and Japan Direct-acting Antiviral Drugs Market Size, Status and Forecast 2021-2027

AbbVie Inc.
GSK
Boehringer Ingelheim
Merck
Novartis
Beximco Pharmaceuticals
Roche
Bristol-Myers Squibb Company
Gilead Sciences
Janssen (Johnson & Johnson)
Vertex Pharmaceuticals
Natco Pharma

Request Sample

Pre-order Enquiry

Request Discount

Global and Japan Direct-acting Antiviral Drugs Market Size, Status and Forecast 2021-2027

Detailed TOC of Global and Japan Direct-acting Antiviral Drugs Market Size, Status and Forecast 2021-2027

List of Figures, Tables and Charts Available in Global and Japan Direct-acting Antiviral Drugs Market Size, Status and Forecast 2021-2027

Keyplayers in Global and Japan Direct-acting Antiviral Drugs Market Size, Status and Forecast 2021-2027

Our Clients